Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.
Key PointsEli Lilly is seeing huge demand for its GLP-1 weight-loss drugs and using the cash influx to diversify.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.